India Coronavirus Dispatch: Short dose gap retained despite contrarian data

How concerned should the nation be about Covid variants, study shows high fatality risk after surgery done within 6 weeks of testing positive, and more-news relevant to India's fight against Covid-19

covid vaccine
FILE PHOTO: A healthcare worker using the vials of COVID-19 vaccine during the second phase of the COVID-19 vaccination at Rajiv Gandhi Super Speciality Hospital in New Delhi
Bharath Manjesh New Delhi
3 min read Last Updated : Mar 13 2021 | 1:48 PM IST
Covishield: Govt retains short dose gap despite research to the contrary

Despite results from a new analysis that indicate a longer gap between Covid-19 vaccine doses yields better clinical results, administrators in India reportedly prefer a shorter gap, a report in The Wire said. The analysis—published in the peer-reviewed medical journal The Lancet last month—found that Covishield’s efficacy is 55.1% when its two doses are given less than six weeks apart but 81.3% when administered 12 weeks apart. India is administering Covishield’s doses 28 days apart. The analysis concludes that increasing the gap also increases the vaccine’s immunogenicity—the ability of a vaccine to trigger an immune response in an individual. Read more here

Does India have plans for a vaccine passport?

India currently does not have plans for a robust vaccine passport system such as the one Israel does, but many are viewing the vaccine certificates as a document that can ease travel restrictions, a report in The Quint said. Several states in the country have also made Covid-19 negative certificates mandatory for those travelling within India. Many states whose economies rely on tourism are hoping the vaccine certificates will be a shot in the arm for the industry that was dealt a blow by the pandemic and the nationwide lockdown. Read more here

EXPLAINED: How concerned should India be about Covid variants?

The central health ministry has said that there is no scientific evidence to show that the recent spike in coronavirus cases can be linked to the three most notable variants of the virus (UK, South Africa, and Brazil), a report in The Indian Express said. “Reporting only the detection does not lead to any attribution for any phenomenon on the ground. Because to relate an occurrence of a virus to change and disease pattern, other epidemiological and clinical information has to be linked to these mutations,” Dr V K Paul, the head of India’s Covid-19 task force, has said.

High fatality risk after surgery done within 6 weeks of testing positive: Study

A new global study has found that patients are two and a half times more likely to die after surgery within six weeks of testing positive for Covid-19, a report in Hindustan Times said. The study recommended that surgery should be delayed for at least seven weeks following a positive diagnosis.
The study took into account 140,231 patients who underwent elective or emergency surgery in 116 countries during October 2020. The findings were published in the journal Anaesthesia. Read more here 

The return of live music 

Live music performances are slowing returning in some parts of the country as Covid restrictions are relaxed, a report in The Indian Express said. The return to normalcy started in September last year with home concerts and small gatherings of about 30-40 people attending "baithaks". While such baithaks are still going on, many hybrid alternatives have emerged which are socially distanced or telecast synchronously virtually, the report said. Read more here 



One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story